FORF.LSE Fortis Frontier PLC

Financial Services Life Sciences Tools & Services London Exchange
0.0825 GBX
Close of Nov 3, 2026
6.50 10.00
Market cap
GBX 2.66M
P/E
8.3x
P/B
0.76x
ROE
-13.2%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is FORF.LSE undervalued?

Graham number
Price0.0825
Graham value0.1561
Discount47.2%

FORF.LSE trades 47.2% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Fortis Frontier PLC fundamental analysis

No fundamental analysis for Fortis Frontier PLC yet.

Fortis Frontier PLC stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Fortis Frontier PLC

Fortis Frontier PLC develops, distributes, and commercializes at-home healthcare and wellness tests in the United Kingdom. It is also involved in the development of an accompanying proprietary digital platform. The company was formerly known as MyHealthChecked PLC and changed its name to Fortis Frontier PLC in November 2025. Fortis Frontier PLC was incorporated in 2008 and is based in Cheltenham, the United Kingdom.

Full company profile